1/31
Comprehensive practice flashcards defining key terminology, mechanisms of action, prototypes, and clinical considerations across general and local anesthetics, anti-anemic agents, neuromuscular junction blockers, and coagulation modifiers.
General Anesthesia
The administration of a combination of medications to achieve analgesia (loss of pain sensation), unconsciousness (loss of awareness), amnesia (loss of memory of the procedure), and the blockage of reflexes to prevent involuntary movement and response to injury.
Balanced Anesthesia
An anesthetic technique combining multiple agents—such as preoperative sedatives, anticholinergics, antiemetics, antihistamines, and opioids—each delivering a specific effect to produce hypnosis, analgesia, and muscle relaxation with minimal toxicity.
Stages of General Anesthesia
The four progressive depths of anesthesia: Stage 1 (analgesia/induction), Stage 2 (excitement/delirium with sympathetic stimulation), Stage 3 (surgical anesthesia with skeletal muscle relaxation and regular respirations), and Stage 4 (medullary depression/paralysis with severe CNS depression and respiratory arrest).

Midazolam
A prototype intravenous benzodiazepine anesthetic that acts primarily at the limbic system and reticular activating system to potentiate gamma-aminobutyric acid (GABA), providing sedation, anxiolysis, and amnesia before and during surgical or diagnostic procedures.
Nitrous Oxide
A potent gas anesthetic supplied in a blue cylinder that depresses the central nervous system to induce rapid anesthesia and analgesia without muscle relaxation; frequently combined with other agents and always administered with oxygen.
Desflurane
A prototype volatile liquid general anesthetic with a rapid onset (1 to 2 minutes) and rapid recovery (15 to 20 minutes) via pulmonary elimination, commonly utilized in outpatient surgeries.
Malignant Hyperthermia
A severe, potentially fatal pharmacogenetic reaction triggered by volatile liquid anesthetics and neuromuscular junction blockers, marked by muscle rigidity, hyperpyrexia, and acidosis; treated with dantrolene.
Bier Block
A technique of intravenous regional local anesthesia where blood is exsanguinated from an extremity using compression tourniquets prior to injecting a local anesthetic into the limb veins to isolate its distribution.
Ester vs. Amide Local Anesthetics
Ester-type local anesthetics (e.g., procaine, tetracaine) contain one "i" in their name and are rapidly hydrolyzed by plasma esterases, whereas amide-type local anesthetics (e.g., lidocaine) contain two "i"s and are metabolized more slowly by the liver.
Lidocaine
A prototype amide local anesthetic that blocks the generation and conduction of action potentials in sensory nerves by reducing sodium permeability; used for infiltration, nerve blocks, spinal anesthesia, and topical surface numbing.
Erythropoiesis
The biological process of erythrocyte formation in the bone marrow, wherein hemocytoblasts differentiate into reticulocytes and mature erythrocytes that circulate for an average lifespan of 120 days.
Erythropoietin Regulatory Loop
A homeostatic physiological mechanism in which decreased arterial oxygen pressure stimulates the kidneys to release erythropoietin, increasing stem cell proliferation and mature red blood cell production to restore tissue oxygen-carrying capacity.

Megaloblastic Anemia
A macrocytic anemia characterized by large, immature red blood cells, resulting from a deficiency in folic acid or vitamin B12​ needed for DNA synthesis and normal erythrocyte stromal structure.
Epoetin Alfa
A prototype erythropoiesis-stimulating glycoprotein that acts like endogenous erythropoietin to stimulate RBC production; carries a boxed warning for increased risk of death, stroke, and deep vein thrombosis when hemoglobin rises above 11g/dL.
Ferrous Sulfate
An oral iron preparation prototype that elevates serum iron concentration for incorporation into hemoglobin or ferritin stores; indicated for prevention and treatment of iron deficiency anemia.
Chelating Agents
Therapeutic compounds (from the Greek word for "claw") that bind molecules of heavy metals to form a soluble, nontoxic complex excreted by the kidneys, preventing the deactivation of vital cellular enzyme systems.
Deferoxamine Mesylate
An iron-chelating agent administered intramuscularly, subcutaneously, or intravenously to treat acute iron intoxication and chronic transfusional iron overload in transfusion-dependent anemias.
Hydroxocobalamin
An intramuscular vitamin B12​ prototype essential for nucleic acid and protein synthesis, hematopoiesis, and maintenance of the myelin sheath; used to treat vitamin B12​ deficiency and pernicious anemia.
Hydroxyurea
A cytotoxic antineoplastic agent that increases fetal hemoglobin production in bone marrow, thereby diluting abnormal hemoglobin S and reducing painful vaso-occlusive crises in patients with sickle cell anemia.
Neuromuscular Junction (NMJ)
The synaptic contact site between a motor neuron terminal and a skeletal muscle fiber, where acetylcholine is released across the cleft to activate postjunctional cholinergic receptors and provoke muscle contraction.
Sliding Filament Mechanism
The biological process in which myosin cross-bridges repeatedly bind to actin filaments and pull them inward toward the center of the sarcomere, shortening the muscle fiber and producing contraction.

Nondepolarizing NMJ Blockers
Skeletal muscle relaxants (e.g., rocuronium, vecuronium) that act as competitive antagonists by occupying nicotinic acetylcholine receptor sites, preventing acetylcholine from binding and inhibiting muscle depolarization.
Rocuronium
A prototype nondepolarizing neuromuscular junction blocking agent with an onset of 45 seconds to 3 minutes, utilized to facilitate endotracheal intubation and induce skeletal muscle relaxation during surgery or mechanical ventilation.
Succinylcholine
The prototype depolarizing neuromuscular blocker that binds to acetylcholine receptors causing initial depolarization and fasciculation, followed by prolonged flaccid paralysis; metabolized by liver-produced plasma cholinesterases.
Hyperkalemic Rhabdomyolysis
A life-threatening complication and pediatric boxed warning for succinylcholine, occurring when acute muscle breakdown in children with undiagnosed myopathies releases massive potassium into the circulation, precipitating cardiac arrest.
Hemostasis
The physiological defense sequence that arrests bleeding following vascular damage, consisting of vascular spasm (vasoconstriction), platelet plug formation, blood coagulation, and clot dissolution (fibrinolysis).
Intrinsic vs. Extrinsic Clotting Pathways
The intrinsic pathway is triggered by internal vascular damage involving Hageman factor, whereas the extrinsic pathway is activated by blood escaping into surrounding injured tissues; both merge into the common pathway to form thrombin and fibrin.
Clopidogrel
An oral antiplatelet prototype whose active metabolite selectively inhibits the P2Y12​ ADP receptor on platelets, preventing subsequent activation of the GPIIb/IIIa receptor complex and decreasing platelet aggregation.
Heparin vs. Warfarin
Heparin is a rapid-acting parenteral anticoagulant that inactivates thrombin and factor Xa via the intrinsic pathway (monitored by aPTT; reversed by protamine sulfate), whereas warfarin is an oral anticoagulant that inhibits vitamin K-dependent factor synthesis via the extrinsic pathway (monitored by PT/INR; reversed by vitamin K).

Alteplase
A recombinant tissue plasminogen activator (tPA) and thrombolytic prototype that enzymatically converts plasminogen to plasmin, lysing fibrin clots, fibrinogen, and other plasma proteins in acute MI, PE, and acute ischemic stroke.
Antihemophilic Factor
A prototype intravenous replacement clotting factor (Factor VIII) required for the transformation of prothrombin to thrombin, used to prevent or manage bleeding episodes in patients with classic hemophilia (hemophilia A).
Aminocaproic Acid
A systemic hemostatic prototype that inhibits plasminogen-activating substances and exerts antiplasmin actions to prevent systemic fibrinolysis and clot breakdown in excessive hyperfibrinolytic bleeding.